← FDA Drug Approvals (Drugs@FDA)
SODIUM PHOSPHATES
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-03-30
Drug application
- FDA Application #
ANDA209997- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM PHOSPHATES
- Generic name
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
- Active ingredients
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2022-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown